Divestiture

The junior miner sheds non-core assets to double down on its high-grade Mexican silver project while upgrading to a top-tier U.S. market.

Singapore's OUE REIT makes a strategic A$357M entry into Australia, acquiring a stake in Sydney's prime, green-certified Salesforce Tower.

Forvia reports a €2.1B net loss but shows improved operations and cash flow. Is this strategic pain a necessary step toward long-term gain?

Industrial packaging giant Greif rewards shareholders, but a closer look at its finances and dual-class stock reveals a company in major transition.

As corporate dentistry grows, one Ann Arbor practice's shift to woman-owned leadership highlights a demand for personalized, health-focused cosmetic care.

Over 1,000 professionals are in Chicago for the NeighborWorks Training Institute, bringing a $5.2M economic boost and new strategies for the housing crisis.

With vet emergencies costing thousands, a new AKC initiative provides a lifeline to low-income owners facing impossible financial decisions.

A lucrative deal for a rare disease voucher positions Fortress Biotech for profitability, highlighting a successful strategy and a breakthrough for Menkes patients.

As cardiovascular disease affects nearly half of US adults, experts are urging a shift to existing, life-saving therapies that are widely ignored.

After halting all R&D, PCI Biotech proposes dissolution and delisting, marking the end for its novel drug delivery platform and a warning for investors.

A 94% surge in water damage claims reveals a growing crisis, yet a new survey shows over half of Canadians plan no action to protect their homes.

Vantage Towers and Gridle partner to transform mobile sites into smart energy hubs, boosting resilience, profits, and sustainability. Here's how.

A landmark Supreme Court decision opens the door for massive tariff refunds. New AI platforms are helping companies quickly navigate the complex claims process.

The FDA is reviewing a new, more affordable alternative to the costly arthritis drug Orencia, potentially saving patients and the healthcare system billions.

Safe Pro Group's AI-powered edge systems are heading to the U.S. Government, a key validation, yet market reaction raises questions about the deal's size.

Despite a reported net loss, the REIT saw a 162% jump in key operational funds and a 22% surge in its senior housing portfolio's income.

F&G Annuities & Life declared its quarterly dividend, offering a sign of stability even as a recent earnings report and stock drop raise questions.

Following massive asset sales and billions in dividends, Array Digital reports surging tower revenue and an optimistic forecast for its new 5G future.

After selling its wireless unit, TDS reports soaring profits and announces aggressive new growth targets for its fiber broadband and tower businesses.

A federal court ruling against Corcept Therapeutics clears a key legal hurdle for Teva's generic Cushing's syndrome drug, rattling investors.